IHC was “MET-positive” showing overexpression (3+) of MET receptor in 70% of tumor cells, whereas FISH analysis revealed clones of tumor cells with MET amplification (53% of tumor cells with ≥5 MET copies, average MET-GCN/cell of 8.2, and 10% of tumor cells with gene clusters of >15 copies). Here, MET is linked to neoplasm.